Reboxetine treatment of depression in Parkinson's disease.
Lemke
M R
MR
D018759:Adrenergic Uptake Inhibitors / Q000008:administration & dosage / Q000627:therapeutic use*; D000368:Aged; D003866:Depressive Disorder / Q000188:drug therapy* / Q000209:etiology / Q000523:psychology; D004334:Drug Administration Schedule; D005260:Female; D006801:Humans; D009025:Morpholines / Q000008:administration & dosage / Q000627:therapeutic use*; D009638:Norepinephrine / Q000037:antagonists & inhibitors / Q000378:metabolism; D010300:Parkinson Disease / Q000150:complications* / Q000523:psychology; D000077593:Reboxetine; D016896:Treatment Outcome
D018759:Adrenergic Uptake Inhibitors; D009025:Morpholines; D000077593:Reboxetine; D009638:Norepinephrine